Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

2018250 citationsJournal Articlebronze Open Access

Authors

Marta Francesca Di Pasquale · University of Milan

Giovanni Sotgiu · University of Sassari

Andrea Gramegna · University of Milan

Dejan Radovanovic · University of Milan

Silvia Terraneo · University of Milan

Luis Felipe Reyes · Universidad de La Sabana

Jan Rupp ·

Abstract

Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.

Topics & Keywords

Pneumocystis jirovecii pneumonia detection and treatment Pneumonia and Respiratory Infections Tuberculosis Research and Epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 68, Issue 9, pp. 1482-1493

DOI: 10.1093/cid/ciy723

Field-Weighted Citation Impact: 8.92